Regeneron Pharmaceuticals, Inc.
Records under this name other than the patents Regeneron Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1,304 patents it holds.
Back to Regeneron Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,785,966 | Humanized M-CSF Mice now held by Institute for Research in Biomedicine (Irb) In force · Low confidence | In force | Low confidence | |
| US 10,927,435 | Compositions for the Treatment of Rheumatoid Arthritis and Methods of Using Same now held by Sanofi Biotechnology In force · Medium confidence | In force | Medium confidence | |
| US 9,371,383 | ANTI-ASIC1 Antibodies and Uses Thereof now held by Regeneron Pharmaceuticlas, Inc. In force · High confidence | In force | High confidence | |
| US 10,433,527 | Genetically Modified Non-Human Animals And Methods Of Use Thereof now held by Institute for Research in Biomedicine (Irb) In force · Low confidence | In force | Low confidence | |
| US 9,901,082 | Genetically Modified Non-Human Animals and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 10,785,968 | Genetically Modified Non-Human Animals and Methods of Use Thereof now held by Yale University In force · High confidence | In force | High confidence | |
| US 9,574,004 | Methods for Treating or Preventing Asthma by Administering an IL-4R Antagonist now held by Sanofi Biotechnology In force · High confidence | In force | High confidence | |
| US 9,943,594 | Methods for the Treatment of Rheumatoid Arthritis now held by Sanofi Biotechnology In force · High confidence | In force | High confidence | |
| US 10,494,442 | Methods for Inhibiting Atherosclerosis by Administering an Inhibitor of PCSK9 now held by Sanofi Biotechnology In force · High confidence | In force | High confidence | |
| US 10,995,150 | Methods for Inhibiting Atherosclerosis by Administering an ANTI-PCSK9 Antibody now held by Sanofi Biotechnology In force · High confidence | In force | High confidence |